Consequently, accumulation of Nrf2 leads to aberrant activation of ARE-driven cytoprotective genes (e.g., HO-1, GCLM, NQO1) in so much as to shelter or promote Nrf1α−/−-driven tumor cells. The gene discussed is NFE2L2; the disease is neoplasm.